Evidence map›Paper›PMID 29178404›Full record

Trial reportMaternal & child nutrition2018

The impact of rickets on growth and morbidity during recovery among children with complicated severe acute malnutrition in Kenya: A cohort study.

Moses M Ngari, Johnstone Thitiri, Laura Mwalekwa, Molline Timbwa, Per Ole Iversen, Greg W Fegan, James A Berkley

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Maternal & child nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00934492 (Randomized, Placebo Controlled Trial of Cotrimoxazole Prophylaxis Amongst HIV-uninfected Children With Severe Malnutrition), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00934492 phase3completednot on this map

Randomized, Placebo Controlled Trial of Cotrimoxazole Prophylaxis Amongst HIV-uninfected Children With Severe Malnutrition

TypeinterventionalSponsorUniversity of OxfordRan2009 to 2014Enrolled1,781ConditionsNutrition Disorders, Life-threatening InfectionArmsCotrimoxazole dispersible tablet, Placebo dispersible tablet
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. High-dose vitamin DNature communications · 2025
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Weight-for-HeightCurrent developments in nutrition · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Moses M NgariKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0001-7149-5491
Johnstone ThitiriKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
Laura MwalekwaKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
Molline TimbwaKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
Per Ole IversenDepartment of Nutrition, IMB, University of Oslo, Oslo, Norway.
Greg W FeganKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0002-2663-2765
James A BerkleyKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0002-1236-849X
Kenya Medical Research Institute · KEOslo University Hospital · NO

Funding

Medical Research Council MR/M007367/1Wellcome TrustWellcome Trust WT083579MA
6 · The paper itself

Abstract

The effects of rickets on children recovery from severe acute malnutrition (SAM) are unknown. Rickets may affect both growth and susceptibility to infectious diseases. We investigated the associations of clinically diagnosed rickets with life-threatening events and anthropometric recovery during 1 year following inpatient treatment for complicated SAM. This was a secondary analysis of clinical trial data among non-human immunodeficiency virus-infected Kenyan children with complicated SAM (2-59 months) followed for 1 year posthospital discharge (ClinicalTrials.gov ID NCT00934492). The outcomes were mortality, hospital readmissions, and growth during 12 months. The main exposure was clinically diagnosed rickets at baseline. Of 1,778 children recruited, 230 (12.9%, 95% CI [11.4, 14 .6]) had clinical signs of rickets at baseline. Enrolment at an urban site, height-for-age and head circumference-for-age z scores were associated with rickets. Rickets at study enrolment was associated with increased mortality (adjusted Hazard Ratio [aHR] 1.61, 95% CI [1.14, 2.27]), any readmission (aHR 1.37, 95% CI [1.09, 1.72]), readmission for severe pneumonia (aHR 1.37, 95% CI [1.05, 1.79]), but not readmission with diarrhoea (aHR 1.05, 95% CI [0.73, 1.51]). Rickets was associated with increased height gain (centimetres), adjusted regression coefficient 0.19 (95% CI [0.10, 0.28]), but not changes in head circumference, mid-upper arm circumference, or weight. Rickets was common among children with SAM at urban sites and associated with increased risks of severe pneumonia and death. Increased height gain may have resulted from vitamin D and calcium treatment. Future work should explore possibility of other concurrent micronutrient deficiencies and optimal treatment of rickets in this high-risk population.

Indexed as

Acute DiseaseChild Nutrition DisordersChild, PreschoolComorbidityDouble-Blind MethodFemaleGrowth DisordersHumansInfantKenyaMaleRicketsSeverity of Illness Indexchildrenmortalityricketssevere acute malnutritionsevere pneumonia

Identifiers

PMID29178404
PMCPMC5901410
OpenAlexW2770069268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.